Radionuclide Therapy A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. Treatment of hyperthyroidism with antithyroid medications must be given for 6 months to 2 years, in order to be effective. The two main antithyroid drugs are: Methimazole and Propylthiouracil Metronidazole and Propranolol Methimazole and Propranolol Metronidazole and Propylthiouracil None 2. Which of the following radioisotopes approved used in the treatment of bone metastases has a significant gamma emission and can be used both for imaging and therapy? P-32 Sr-89 Sm-153 Ra-223 None 3. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: Blocking thyroid uptake of free radioiodine Performing pulmonary function tests A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Reviewing potential interfering medications None 4. To reduce radiation exposure to the patient undergoing radioactive iodine (RAI) treatment, all of the following recommendations will be helpful EXCEPT: Patient should urinate frequently Patient should use antiperspirant medications Patient should be well hydrated Patient laxatives None 5. According to the Society of Nuclear Medicine “SNM Procedure Guideline for Therapy of Thyroid Disease with I-131 (Sodium Iodide),” typically administered activity for treatment of presumed thyroid cancer in the neck or mediastinal lymph nodes is in the range: 100–150 mCi. 50–100 mCi. 200–250 mCi. 150–200 mCi. None 6. All breastfeeding women undergoing I-131 therapy should be asked to stop breastfeeding and therapy is delayed until lactation ceases. According to the Society of Nuclear Medicine (SNM) procedure guidelines, the patient may resume breastfeeding: After 6 months. After 3 months. Never. With the birth of another child. None 7. A lone “cold” nodule in an otherwise normal thyroid gland warrants: Fine needle aspiration biopsy. Surgical removal. Chemotherapy. Radiation therapy. None 8. Iodine-131 is considered to be the treatment of choice in many patients with Graves’ disease. The most common side effect of radioactive iodine (RAI) treatment is: Hyperthyroidism Thyroiditis Thyroid carcinoma Hypothyroidism None 9. What is the predominant toxicity of radioisotopes used in the treatment of bone metastases? Leukemia Radiation pneumonitis Myelosuppression Gastritis None 10. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Fever Arrhythmia Bruising Anemia None 1 out of 10 Time's upTime is Up! By Nasser AlMutairi|2021-03-30T09:35:30+03:00March 30th, 2021| شارك هذه الصفحة FacebookXLinkedInWhatsAppPinterestEmail About the Author: Nasser AlMutairi Senior Nuclear Medicine Specialist at Hafar Al-Batin Central Hospital, Founder of NuclearMed Website. Leave A Comment Cancel replyComment Δ
Leave A Comment